|
1
|
Katsarou A, Gudbjörnsdottir S, Rawshani A,
Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA and
Lernmark Å: Type 1 diabetes mellitus. Nat Rev Dis Primers.
3:170162017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bansal D, Gudala K, Muthyala H, Esam HP,
Nayakallu R and Bhansali A: Prevalence and risk factors of
development of peripheral diabetic neuropathy in type 2 diabetes
mellitus in a tertiary care setting. J Diabetes Investig.
5:714–721. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Adeshara KA, Diwan AG and Tupe RS:
Diabetes and complications: Cellular signaling pathways, current
understanding and targeted therapies. Curr Drug Targets.
17:1309–1328. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gregg EW, Sattar N and Ali MK: The
changing face of diabetes complications. Lancet Diabetes
Endocrinol. 4:537–547. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Magee C, Grieve DJ, Watson CJ and Brazil
DP: Diabetic Nephropathy: A tangled web to unweave. Cardiovasc
Drugs Ther. 31:579–592. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han Q, Zhu H, Chen X and Liu Z:
Non-genetic mechanisms of diabetic nephropathy. Front Med.
11:319–332. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharma D, Bhattacharya P, Kalia K and
Tiwari V: Diabetic nephropathy: New insights into established
therapeutic paradigms and novel molecular targets. Diabetes Res
Clin Pract. 128:91–108. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Harrow J, Frankish A, Gonzalez JM,
Tapanari E, Diekhans M, Kokocinski F, Aken BL, Barrell D, Zadissa
A, Searle S, et al: GENCODE: The reference human genome annotation
for The ENCODE Project. Genome Res. 22:1760–1774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guttman M, Donaghey J, Carey BW, Garber M,
Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al:
LincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
He X, Ou C, Xiao Y, Han Q, Li H and Zhou
S: LncRNAs: Key players and novel insights into diabetes mellitus.
Oncotarget. 8:71325–71341. 2017.PubMed/NCBI
|
|
16
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bhan A and Mandal SS: Long noncoding RNAs:
Emerging stars in gene regulation, epigenetics and human disease.
ChemMedChem. 9:1932–1956. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu B, Zhang C, Zou L, Ma Y, Huang K, Lv Q,
Zhang X, Wang S, Xue Y, Yi Z, et al: LncRNA uc.48+ siRNA improved
diabetic sympathetic neuropathy in type 2 diabetic rats mediated by
P2×7 receptor in SCG. Auton Neurosci. 197:14–18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Allison SJ: Diabetic nephropathy: A lncRNA
and miRNA megacluster in diabetic nephropathy. Nat Rev Nephrol.
12:7132016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duan LJ, Ding M, Hou LJ, Cui YT, Li CJ and
Yu DM: Long noncoding RNA TUG1 alleviates extracellular matrix
accumulation via mediating microRNA-377 targeting of PPARγ in
diabetic nephropathy. Biochem Biophys Res Commun. 484:598–604.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang M, Wang S, Yao D, Yan Q and Lu W: A
novel long non-coding RNA CYP4B1-PS1-001 regulates proliferation
and fibrosis in diabetic nephropathy. Mol Cell Endocrinol.
426:136–145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu M, Wang R, Li X, Fan M, Lin J, Zhen J,
Chen L and Lv Z: LncRNA MALAT1 is dysregulated in diabetic
nephropathy and involved in high glucose-induced podocyte injury
via its interplay with β-catenin. J Cell Mol Med. 21:2732–2747.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen S, Dong C, Qian X, Huang S, Feng Y,
Ye X, Miao H, You Q, Lu Y and Ding D: Microarray analysis of long
noncoding RNA expression patterns in diabetic nephropathy. J
Diabetes Complications. 31:569–576. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Zhu Y and Wang R: Long noncoding
RNAs in respiratory diseases. Histol Histopathol. 119662018.
|
|
28
|
Sallam T, Sandhu J and Tontonoz P: Long
noncoding RNA discovery in cardiovascular disease: Decoding form to
function. Circ Res. 122:155–166. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saha P, Vermas S, Pathak RU and Mishra RK:
Long noncoding RNAs in mammalian development and diseases. Adv Exp
Med Biol. 1008:155–198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leung A and Natarajan R: Long noncoding
RNAs in diabetes and diabetic complications. Antioxid Redox Signal.
Oct 30–2017.(Epub ahead of print).
|
|
31
|
Sun Y and Liu YX: LncRNA HOTTIP improves
diabetic retinopathy by regulating the p38-MAPK pathway. Eur Rev
Med Phamacol Sci. 22:2941–2948. 2018.
|
|
32
|
Zhang N, Geng T, Wang Z, Zhang R, Cao T,
Camporez JP, Cai SY, Liu Y, Dandolo L, Shulman GI, et al: Elevated
hepatic expression of H19 long noncoding RNA contributes to
diabetic hyperglycemia. JCI Insight. 3(pii): 1203042018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yan B, Yao J, Liu JY, Li XM, Wang XQ, Li
YJ, Tao ZF, Song YC, Chen Q and Jiang Q: lncRNA-MIAT regulates
microvascular dysfunction by functioning as a competing endogenous
RNA. Circ Res. 116:1143–1156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Alvarez ML and DiStefano JK: Functional
characterization of the plasmacytoma variant translocation 1 gene
(PVT1) in diabetic nephropathy. PLoS One. 6:e186712011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hamzawy M, Gouda SAA, Rashid L, Attia
Morcos M, Shoukry H and Sharawy N: The cellular selection between
apoptosis and autophagy: Roles of vitamin D, glucose and immune
response in diabetic nephropathy. Endocrine. 58:66–80. 2017.
View Article : Google Scholar : PubMed/NCBI
|
